AI assistant
JATCORP LIMITED — Capital/Financing Update 2017
Dec 12, 2017
65154_rns_2017-12-12_ab3d0226-4199-498b-b6aa-dc03a2535653.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [189 x 57] intentionally omitted <==
13 December 2017
Jatenergy Limited (“JAT”) is pleased to announce it has secured approximately $1.2 million in funds through the issue of convertible notes (“Notes”) to investors who include potential distributors of products being sold into China.
The funds raised from the issue of the notes are immediately available to finance the manufacture, on behalf of JAT, of a dairy based infant formula and the regulatory work required to obtain CFDA approval for the formula to be sold in China.
Convertible Note Terms
The key terms of the Notes include
-
The total amount subscribed by 10 investors is approximately $1.2 million.
-
The notes are repayable in six months’ time unless the Notes are converted to shares in JAT within that time.
-
The Notes are mandatorily convertible into shares at the conversion price if the conversion is approved by shareholders of JAT as a general meeting. JAT is required to arrange to hold a general meeting of shareholders within three months.
-
The conversion price is 3.5 cents per share. The number of shares to be issued will therefore be approximately 34,285,000.
-
The issue is not underwritten.
Jatenergy intends to hold a general meeting of shareholders in February 2018 to seek approval of shareholders for the conversion of the Notes into fully paid ordinary shares of JAT.
Anthony Crimmins +61 2 9571 8300 [email protected]